Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study

Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 20...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 135; no. 18; pp. 2245 - 2247
Main Authors Bai, Wei, Li, Mengtao, Zhou, Shuang, Peng, Liying, Zhao, Jiuliang, Tian, Xinping, Wang, Qian, Leng, Xiaomei, Zhang, Shangzhu, Wang, Yanhong, Zhao, Yan, Zeng, Xiaofeng
Format Journal Article
LanguageEnglish
Published China Lippincott Williams & Wilkins 20.09.2022
Lippincott Williams & Wilkins Ovid Technologies
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 2020 in Peking Union Medical College Hospital. According to the European consensus criteria, SLE remission was defined as a clinical SLEDAI-2K = 0 and PGA <0.5, with prednisolone (or equivalent) ≤5 mg daily. Pulmonary arterial hypertension (PAH) was defined as a resting mean pulmonary artery pressure >25 mmHg assessed by right heart catheterization, in the presence of normal pulmonary capillary wedge pressure <15 mmHg and pulmonary vascular resistance >3 Wood units, or a resting systolic pulmonary artery pressure >40 mmHg estimated by transthoracic echocardiography. According to our study, tacrolimus combined with or without vasodilator therapy might improve not only the SLEDAI-2K score but also the heart function of patients with SLE-PAH.
AbstractList Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 2020 in Peking Union Medical College Hospital. According to the European consensus criteria, SLE remission was defined as a clinical SLEDAI-2K = 0 and PGA <0.5, with prednisolone (or equivalent) ≤5 mg daily. Pulmonary arterial hypertension (PAH) was defined as a resting mean pulmonary artery pressure >25 mmHg assessed by right heart catheterization, in the presence of normal pulmonary capillary wedge pressure <15 mmHg and pulmonary vascular resistance >3 Wood units, or a resting systolic pulmonary artery pressure >40 mmHg estimated by transthoracic echocardiography. According to our study, tacrolimus combined with or without vasodilator therapy might improve not only the SLEDAI-2K score but also the heart function of patients with SLE-PAH.
Author Tian, Xinping
Li, Mengtao
Zhang, Shangzhu
Zeng, Xiaofeng
Peng, Liying
Wang, Qian
Zhou, Shuang
Zhao, Yan
Zhao, Jiuliang
Leng, Xiaomei
Bai, Wei
Wang, Yanhong
AuthorAffiliation Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China
AuthorAffiliation_xml – name: Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China
– name: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Author_xml – sequence: 1
  givenname: Wei
  surname: Bai
  fullname: Bai, Wei
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 2
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 3
  givenname: Shuang
  surname: Zhou
  fullname: Zhou, Shuang
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 4
  givenname: Liying
  surname: Peng
  fullname: Peng, Liying
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 5
  givenname: Jiuliang
  surname: Zhao
  fullname: Zhao, Jiuliang
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 6
  givenname: Xinping
  surname: Tian
  fullname: Tian, Xinping
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 7
  givenname: Qian
  surname: Wang
  fullname: Wang, Qian
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 8
  givenname: Xiaomei
  surname: Leng
  fullname: Leng, Xiaomei
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 9
  givenname: Shangzhu
  surname: Zhang
  fullname: Zhang, Shangzhu
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 10
  givenname: Yanhong
  surname: Wang
  fullname: Wang, Yanhong
  organization: Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China
– sequence: 11
  givenname: Yan
  surname: Zhao
  fullname: Zhao, Yan
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 12
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
  organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35946790$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vEzEQhi1URNPCP0BoJS5ctvh77d5QxEelIi5wtma9XuLgXQfbS5R_j0NahHLCB49m9Mwrj9-5QhdznB1CLwm-IVh3b9ef9Q3-51CG6RO0ooLTVkhOLtAKMylbqbW-RFc5bysjRCefoUsmNJedxisU18HP3kJo3DjWaA9NHJsCNsXgpyU3fm7yIRc3eduEZVcrLh3Kxk1QYq7Z3pdN8wuSjzWZYPajywWKj3O-baBJDkK7jykMTS7LcHiOno4QsnvxEK_Rtw_vv64_tfdfPt6t3923lmvK2g4LOlLHCONsID2lRMrRdRxkryzulQMBVikuB9CcOSJ721mqBGbD6Kzq2TW6O-kOEbZml_wE6WAiePOnENN3A6l4G5xR_cAHIYmrN-cj6QfGFGBNtMJYAVStNyetXYo_lzqemXy2LgSYXZ3a0A5jyRSRuqKvz9BtXNJcJ62U4Jp0ojtSrx6opZ_c8Pd5j7ZU4PYEVBtyTm401p8-tSTwwRBsjjtg6g6Y8x2ozfys-VH__9r2MRSX8o-w7F0ym2pg2RxxqhnDLcWUYk0xbmuJMPYbKx7C5w
CitedBy_id crossref_primary_10_3390_jcm13041047
Cites_doi 10.1183/13993003.02449-2016
10.1136/annrheumdis-2020-216924
10.1177/0961203313499086
10.1136/annrheumdis-2015-207726
10.1136/annrheumdis-2013-205139
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1097/CM9.0000000000002302
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2542-5641
EndPage 2247
ExternalDocumentID oai_doaj_org_article_8bd4d561e4d544f1bd338a09198008aa
35946790
10_1097_CM9_0000000000002302
00029330-202209200-00013
Genre Letter
Correspondence
GroupedDBID ---
-05
-0E
0R~
29B
2WC
40I
5GY
5RE
5VR
5VS
6J9
7X7
88E
8FI
8FJ
92F
92I
92M
AAAAV
AAHPQ
AAIQE
AASCR
ABASU
ABCQX
ABDIG
ABUWG
ABVCZ
ABZZY
ACGFO
ACGFS
ACILI
ACXJB
ADGGA
ADHPY
ADPDF
AENEX
AFBFQ
AFDTB
AFKRA
AHMBA
AHQNM
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
ALIPV
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BENPR
BPHCQ
BQLVK
BVXVI
CCEZO
CCPQU
CHBEP
CIEJG
CW9
DIK
DIWNM
EBS
EEVPB
EJD
F5P
FA0
FCALG
FRP
FYUFA
GNXGY
GQDEL
GROUPED_DOAJ
GX1
HLJTE
HMCUK
HYE
IAO
IHR
IKREB
IPNFZ
JUIAU
KQ8
L7B
M1P
M48
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
P2P
P6G
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RLZ
RNS
RPM
RT5
S..
T8U
TCJ
TEORI
TGQ
TR2
TSPGW
U1F
U5O
UKHRP
W2D
WFFXF
XSB
AAYXX
CITATION
OVT
3V.
ABXLX
CGR
CUY
CVF
ECM
EIF
NPM
Q--
Q-4
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c4923-7052f2e31343d1b22166fe74a6b8c0b8ea5ac8846da943e16bc7c28503dfec8b3
IEDL.DBID M48
ISSN 0366-6999
2542-5641
IngestDate Wed Aug 27 01:28:18 EDT 2025
Fri Jul 11 08:07:31 EDT 2025
Fri Jul 25 09:34:34 EDT 2025
Wed Feb 19 02:23:16 EST 2025
Thu Apr 24 23:07:37 EDT 2025
Thu Jul 03 08:10:52 EDT 2025
Fri May 16 03:50:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4923-7052f2e31343d1b22166fe74a6b8c0b8ea5ac8846da943e16bc7c28503dfec8b3
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1097/CM9.0000000000002302
PMID 35946790
PQID 2754917579
PQPubID 2042885
PageCount 3
ParticipantIDs doaj_primary_oai_doaj_org_article_8bd4d561e4d544f1bd338a09198008aa
proquest_miscellaneous_2700638169
proquest_journals_2754917579
pubmed_primary_35946790
crossref_citationtrail_10_1097_CM9_0000000000002302
crossref_primary_10_1097_CM9_0000000000002302
wolterskluwer_health_00029330-202209200-00013
PublicationCentury 2000
PublicationDate 2022-September-20
PublicationDateYYYYMMDD 2022-09-20
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-September-20
  day: 20
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
– name: Baltimore
PublicationTitle Chinese medical journal
PublicationTitleAlternate Chin Med J (Engl)
PublicationYear 2022
Publisher Lippincott Williams & Wilkins
Lippincott Williams & Wilkins Ovid Technologies
Wolters Kluwer
Publisher_xml – name: Lippincott Williams & Wilkins
– name: Lippincott Williams & Wilkins Ovid Technologies
– name: Wolters Kluwer
References Spiekerkoetter (R5-20250603) 2017; 50
van Vollenhoven (R1-20250603) 2014; 73
Franklyn (R4-20250603) 2016; 75
Fanouriakis (R2-20250603) 2020; 79
Li (R3-20250603) 2013; 22
References_xml – volume: 50
  start-page: 1602449
  year: 2017
  ident: R5-20250603
  article-title: Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02449-2016
– volume: 79
  start-page: 713
  year: 2020
  ident: R2-20250603
  article-title: 2019 update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-216924
– volume: 22
  start-page: 1192
  year: 2013
  ident: R3-20250603
  article-title: Chinese SLE treatment and research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203313499086
– volume: 75
  start-page: 1615
  year: 2016
  ident: R4-20250603
  article-title: Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-207726
– volume: 73
  start-page: 958
  year: 2014
  ident: R1-20250603
  article-title: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-205139
SSID ssj0025576
Score 2.3157163
Snippet Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics...
SourceID doaj
proquest
pubmed
crossref
wolterskluwer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2245
SubjectTerms Arthritis
Cardiac catheterization
Humans
Hypertension
Immunosuppressive agents
Immunosuppressive Agents - therapeutic use
Intubation
Lupus
Lupus Erythematosus, Systemic - drug therapy
Proteins
Pulmonary arteries
Remission (Medicine)
Tacrolimus - therapeutic use
Thrombocytopenia
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9JSSr-zSVpU6FXE-rSVWxIaQmF7aiA3I8kShG7tEO-25N93xpKXJBRyqQ8G2bKxNSPPGz_piZAvStXCW4cMq5JMdY1mDnJs1gUrY-KuShonCi-_m_ML9e1SX95Z6gvHhGV54Nxwh43vVAdBPsJeqcR9B0mVgyhnAeo0boJGUJqTqZJqaV0XltIwAxhonjRn68PTpc2ihWUDDC7uBaVJu_9fgPM5efFnQA57_DkNYb8TiM5ekZcFQdLj_OSvyZPYvyFPl4Ujf0uGIvW5ohHlIVy4pUOiaxdwfZ5fm5Fe9TTrN18Futpcw5F4c5vFW4cRSvhrlv6GHHqAAspjpDhmwn48oo4CylyxSWiVTtq078jF2dcfp-esLKvAAqqxsbrSIokouVSy414IbkyKtXLGN6HyTXTahQZwSeeskpEbH-ogGl3JLsXQePme7PRDH3cJFdyhYJkzMigVUu2FEU7xEFQ0VayqBZFzu7ahaI7j0herdua-wRrtQ2ssCNtedZ01Nx6pf4Im29ZFxezpAPhRW_yofcyPFuRgNnhbuvHYihrSZwBYtV2Qz9vT0AGRVXF9BDu0yNwbpF-hzofsKNsnkdpCILLQDuye57R5kiu-icA_SvCtEuDFIs_y53Lvf7zRPnmGt8XBLaI6IDvrm038CAhq7T9NneUvIH8Qgw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1di9QwFA26giiy-LmOrhLB17BtkiaNL6KLyyKMTy7MW0nSRBbHdnY6o-y_994mnXVl0T4U0iaQ9ubj3JzkXELeSqm5MxYZVimYbOuKWfCxWeuNCLG0RazwoPD8izo9k58X1SIvuA15W-U0Jo4Dddt7XCM_4ho8GZjrtHm_umAYNQrZ1RxC4za5g9Jl2Kr14srhqiqduUrFFCCh6eic0UfHc5OkC_MFSJxfm5pGBf-bYOd98uBXj0z28H3cyP7HdHTykOxnHEk_JMM_IrdC95jcnWem_Anps-DnkgYUibD-kvaRbqzHKD0_tgM972hScT73dLldwZOwvkwSrv0AKVygpT_Bk-4hgSIZMQyJth_eUUsBay7ZKLdKR4Xap-Ts5NPX41OWgyswj5psTBcVjzyIUkjRlo7zUqkYtLTK1b5wdbCV9TWgk9YaKUKpnNee11Uh2hh87cQzstf1XXhOKC8typZZJbyUPmrHFbey9F4GVYSimBEx_dfGZ-VxDICxbCYGHKzR_G2NGWG7UqukvPGf_B_RZLu8qJs9PujX35rcDZvatbIFyBjgLmUsXQsuugXMZAA419bOyOFk8CZ35qG5anoz8mb3Grohciu2C2CHBvl7hSQs5DlIDWVXE1EZmI4M_Ad2reU06agrfgnHdSUYsTgvDE9n_Uvx4t-VeUnuYQHcvMKLQ7K3WW_DK0BIG_d67Aa_AW4BCHU
  priority: 102
  providerName: ProQuest
Title Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-202209200-00013
https://www.ncbi.nlm.nih.gov/pubmed/35946790
https://www.proquest.com/docview/2754917579
https://www.proquest.com/docview/2700638169
https://doaj.org/article/8bd4d561e4d544f1bd338a09198008aa
Volume 135
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ta9UwFA5zA1FEfN_VeYng10jz0qQdyNjG5hDuEPHC_VaSNJVhbbfbe9X773dO33AyEfsh0DYNbU5enpOneQ4hb5UywqUWGVYlmcqTmFnwsVnuUxkKbqMixo3Cs3N9NlcfF_FiiwwxW_sKbG517TCe1HxZvvt1tTmADv9-EGA8nqWdDGF_AKqGQXkH5iaDMQ1mauQVAD-bnr3UTAM2GjbT_aWUG5NVq-l_GxC9Tx78rJHbbr61v7b_NkGdPiIPe2RJD7um8JhsheoJuTvrufOnpO4lQEsaUDbC-g2tC7qyHuP2fF839KKina7zhafl-hKuhOWmE3WtGzjDJVv6A3zrGk5QNqMITUfkN_vUUkCfJWsFWGmrWfuMzE9PvhyfsT7cAvOo0sZMFItCBMmlkjl3QnCti2CU1S7xkUuCja1PAK_kNlUycO288SKJI5kXwSdOPifbVV2FXUIFtyhkZrX0SvnCOKGFVdx7FXQUomhC5FCvme-1yDEkRpkNnDhYI_vTGhPCxqcuOy2Of-Q_QpONeVFJu71QL79mfcfMEperHEBkgFSpgrscnHYLKCoFKJ1YOyF7g8GzoXVmwoBbDcDLpBPyZrwNHRPZFlsFsEOGjL5GWhbyvOgayvgmMk5hgkqhHtiNlpN1m1_xSwSuNMEYJkSUim73P5cv_7MGXpF7WAL-3yKiPbK9Wq7DawBRKzcld8zCTMnO0cn5p8_TdikC0g8LPm17zDVUTBPB
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIfEhhPgYUBhgJHi05tiOkyAhBIOpY-ueNqlvxnEcNFGa0rRM_af4G7nLR8cQgqf1oVISJ0p8Z9_vfOffAbzUOpF55ijCqhXXRRpzhz42L3ymQhk5Uca0UXh0ZIYn-tM4Hm_Az34vDKVV9nNiM1EXlac18h2ZoCeDti7J3s6-c6oaRdHVvoRGqxYHYXWGLlv9Zv8DyveVlHsfj3eHvKsqwD2RkfFExLKUQUVKqyLKpYyMKUOinclTL_I0uNj5FM1y4TKtQmRyn3iZxkIVZfBprvC5V-AqGl5Bzl4yPnfw4jjpYqOGG0Re_Va9LNnZHWUtVWL3Q-QvL5jCpmLA32DuTbh1VlHkvP7aJM7_Zv727sDtDreyd62i3YWNML0H10ZdZP4-VB3B6IQFIqVwfsWqki2cp6pA35Y1O52yljX61LPJcoZnwnzVUsZWNR7RgjD7gZ57hQdEylGGuk0TqF8zxxDbTnhD78oaRtwtOLmUbn8Am9NqGh4Bk5EjmjRnlNfal0kujXQ68l4HI4IQA1B9v1rfMZ1TwY2J7SPuKA37pzQGwNd3zVqmj_-0f08iW7clnu7mRDX_Yrthb9O80AVC1ID_WpdRXiiVOsRoGQL11LkBbPcCt93kUdtzVR_Ai_VlHPYUy3HTgHKwlC9gKOiLbR62irJ-ExVnaP4y7Ad-QXNsu7WWvkTSOhbOkFKKTLbcApF6_O-XeQ7Xh8ejQ3u4f3TwBG7QzZQ4I8U2bC7my_AU0dkif9YMCQafL3sM_gKxfkTm
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ00ghPimMMBIkLegxHYcBykPox_sg3aTtsF4Co7joInSVE27qf89d_moGAIhHtaHtkmcKvXZ59_57n5HyGshQpZGGj2sgrsiU4GrwcZ2MxNxm_vaywNMFB6N5e6p2D8LzjZIW6wBk8_K2Vv8qNQ0fsFyOGgXnsT7x07vuBd_ccaDz8fx2Dna-TCotqkxSMI56g_jldOPi4t84fQP45afsTeKapbC5gWgmzWZHwd2dQk2Xhnv9WFAvGFsODjp7bpNGQLXIHuZG3oBy5nlPhc881PGfClzGwotU2W8VFkdaKNgHc90JLj1ZWpCw1Tg8Sy3RqUcfvcG2VQKLIcO2Tz8NBj01zZhEISNO1W6EsBam933l-e-snpWRQb-hIxvkduXBTrby-9VrP0vK-bwLrnTQF26U4_Ne2TDTu-TrVHjzH9AioaTdEIt8lhos6JFThfaYCGhH8uSnk9pTTR9buhkOYMzdr6qWWaLEo5wD5legLFfwAHyeOS2rCMLyndUU4DDE7dihKUVie5DcnotHf-IdKbF1D4hlPkamdW05EYIk4cpk0wL3xhhpWc9r0t426-JacjRsUbHJGmd9CCN5HdpdIm7vmtWk4P8o_17FNm6LVJ7VyeK-bek0RSJSjORAaq18C5E7qcZ50oDrIsA2yutu2S7FXjS6JsyYSHY-YAEw6hLXq0vg6ZA94-eWpBDgiEGEv3E0OZxPVDWT8KDCFbMCPrBvTJykjobF_8Jw60vUKqMeRGr6Qh8_vQ_278kWzBNk49744Nn5CZexNgb5m2TzmK-tM8B4C3SF80koeTrdc_Ln5hCVOo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+efficacy+of+tacrolimus+in+systemic+lupus+erythematosus+with+various+manifestations%3A+a+real-world+study&rft.jtitle=Chinese+medical+journal&rft.au=Bai%2C+Wei&rft.au=Li%2C+Mengtao&rft.au=Zhou%2C+Shuang&rft.au=Peng%2C+Liying&rft.date=2022-09-20&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=135&rft.issue=18&rft.spage=2245&rft.epage=2247&rft_id=info:doi/10.1097%2FCM9.0000000000002302&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_CM9_0000000000002302
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0366-6999&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0366-6999&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0366-6999&client=summon